Zyla Life Sciences Debt Instrument, Unamortized Discount
Zyla Life Sciences had Debt Instrument, Unamortized Discount of $4.74 million as of 2020-03-31, per its 10-Q filed 2020-05-14.
Discontinued › Notes › Debt › Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net
us-gaap:DebtInstrumentUnamortizedDiscount · last filed 2020-05-14
- 2020-03-31: Debt Instrument, Unamortized Discount $4.74M.
- 2019-12-31: Debt Instrument, Unamortized Discount $5.01M.
- 2019-09-30: Debt Instrument, Unamortized Discount $5.82M.
- 2019-06-30: Debt Instrument, Unamortized Discount $7.67M.
| Period end | Debt Instrument, Unamortized Discount | Debt Instrument, Unamortized Discount as first filed |
|---|---|---|
| 2020-03-31 | $4.74M 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $5.01M 10-Q · filed 2020-05-14 | |
| 2019-09-30 | $5.82M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $7.67M 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $9.43M 10-Q · filed 2019-05-17 | |
| 2018-06-30 | $20.83M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $20.90M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $20.92M 10-Q · filed 2018-08-09 | $7.57M 10-K · filed 2018-03-16 |
| 2017-03-31 | $20.92M 10-Q · filed 2018-05-10 | |
| 2016-12-31 | $5.19M 10-K · filed 2018-03-16 |